Literature DB >> 6814930

Effect of the benzodiazepine receptor antagonist Ro 15-1788 on the anticonvulsant and anticonflict actions of MK-801.

B V Clineschmidt.   

Abstract

MK-801, phenobarbital and clonazepam blocked convulsions elicited in mice by bicuculline. Treatment with Ro 15-1788 antagonized the anticonvulsant action of clonazepam, but not MK-801 or phenobarbital. The anticonflict effect in the rat of chlordiazepoxide, but not MK-801, was antagonized by Ro 15-1788. Despite having certain benzodiazepine-like effects in vivo, MK-801 does not act directly or indirectly via receptors for benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6814930     DOI: 10.1016/0014-2999(82)90167-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Effect of psychotomimetics and some putative anxiolytics on stress-induced hyperthermia.

Authors:  A Lecci; F Borsini; L Gragnani; G Volterra; A Meli
Journal:  J Neural Transm Gen Sect       Date:  1991

2.  The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK-801: a voltage clamp study on neuronal cells in culture.

Authors:  R F Halliwell; J A Peters; J J Lambert
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

3.  Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.

Authors:  W Löscher; D Hönack
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

4.  Using drug combinations to assess potential contributions of non-GABAA receptors in the discriminative stimulus effects of the neuroactive steroid pregnanolone in rats.

Authors:  Amy K Eppolito; Hanna R Kodeih; Lisa R Gerak
Journal:  Physiol Behav       Date:  2014-07-26

5.  Effect of Berberine on Cell Survival in the Developing Rat Brain Damaged by MK-801.

Authors:  Taehwan Lee; Hwon Heo; Yunhee Kim Kwon
Journal:  Exp Neurobiol       Date:  2010-12-31       Impact factor: 3.261

Review 6.  Time to re-engage psychiatric drug discovery by strengthening confidence in preclinical psychopharmacology.

Authors:  Mark David Tricklebank; Trevor W Robbins; Camilla Simmons; Erik H F Wong
Journal:  Psychopharmacology (Berl)       Date:  2021-03-10       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.